em>Joel Elconin is the co-host of Benzinga's #PreMarket Prep, a daily trading idea radio show.
Regeneron Pharmaceuticals REGN shares are trading higher by $31.60 at $531.59 in Tuesday's session. Besides a strong rally in the broad market, an UBS upgrade from Sell to Buy has sparked a rally in the issue.
Before today's rally, Regeneron ended Friday's session at $499.99, which was less than $20 from its flash crash low of $480.50. While the broad market and many other issues have rebounded nicely from those lows, Regeneron was much closer to the panc low than it was its recovery high of $547.15.
After a higher open, ($514.88), it only declined to $510.13 before resuming its rally. So far, it has found intraday resistance ahead of its August 31 high ($534.72), only reaching $534 before retreating to its current level.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in